Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen Arginine and Neural Mobilization in Carpal Tunnel Syndrome
NCT06778759Phase 4Completed
- Sponsor
- Universidad Europea de Madrid
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ibuprofen arginine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Universidad Europea de Madrid. Primary endpoint: Distal upper limb pain at 2 weeks. Started Feb 2025; status: completed.
02
Drugs
ibuprofen arginine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT06778759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06778759.